As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

Integrating behavioral health into primary care is cost-effective from the US health system perspective, with reduced prescription drug expenses being a key driver of these savings. Objective: To ...

The inclusion of dynamic drug pricing in cost-effectiveness analysis is important for value assessments of new drugs. The drug price-related provisions of the Inflation Reduction Act make the case for ...

Several new treatment combinations have been approved in metastatic renal cell carcinoma (mRCC). To determine the optimal therapy on the basis of cost and health outcomes, we performed a ...